Change Language

Select Language

Global Nebulizers Market to Reach US$ 1.9 Billion by 2027, Impelled by Higher Incidences of Respiratory Diseases

Published on Sep 26, 2019

The latest report by IMARC Group, titled “Nebulizers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global nebulizers market size reached US$ 1.2 Billion in 2021. Nebulizers are medical devices used for the direct delivery of medication into the human respiratory system. These electric or battery-powered machines convert the liquid drug into an aerosol form of mist or fine spray by utilizing compressed air. The essential components of a nebulizer include an air compressor, compressor tubing, nebulizer cup and a facemask or mouthpiece for inhaling. Nebulizers are generally prescribed to people suffering from a chronic progressive condition of lung disorders such as chronic bronchitis, pneumonia, and asthma. Nowadays, several types of nebulizers are used in hospitals, clinics and homes as they are cost-effective, user-friendly and provide immediate relief and long-lasting effect.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Nebulizers Market Trends:

Based on the nebulizer market research, hectic and stressful lifestyles have stimulated the rate of tobacco consumption, particularly in developing countries. This trend, along with the growing geriatric population and rising air pollution levels, has led to the increasing prevalence of chronic respiratory diseases, such as asthma and cystic fibrosis, in turn, boosting the demand for nebulizers across the globe. Also, various healthcare organizations are taking initiatives to improve the awareness of and access to respiratory care devices such as nebulizers among patients. Moreover, the leading pharmaceutical companies are introducing ultrasonic nebulizers with enhanced functionality, high efficiency, increased portability and drug exposure, and low drug delivery time for people who are unable to breathe deeply. Owing to these factors, the market value is projected to reach US$ 1.9 Billion by 2027, expanding at a CAGR of 7.7% during 2022-2027.

Market Summary:

  • Based on the product type, the market has been segmented as pneumatic, ultrasonic, mesh and other nebulizers.
  • On the basis of the portability, standalone nebulizers represent the largest segment, followed by portable nebulizers.
  • Based on the end-user, the market has been segregated into hospitals and clinics, long term healthcare centers, homecare settings and outpatient settings.
  • The market has been categorized on the basis of the application into chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma and others.
  • Region-wise, the market has been divided into North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
  • The competitive landscape of the market is characterized by the presence of small and large manufacturers operating in the industry. Some of the global nebulizers market competitors include Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us


USA: +1-631-791-1145
Follow us on twitter: @imarcglobal


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at